Navigation Links
Unravelling the Northwest's Viking past
Date:2/8/2008

The blood of the Vikings is still coursing through the veins of men living in the North West of England according to a new study which has been just published.

Focusing on the Wirral in Merseyside and West Lancashire the study of 100 men, whose surnames were in existence as far back as medieval times, has revealed that 50 per cent of their DNA is specifically linked to Scandinavian ancestry.

The collaborative study, by The University of Nottingham, the University of Leicester and University College London, reveals that the population in parts of northwest England carries up to 50 per cent male Norse origins, about the same as modern Orkney. The 14-strong research team, funded by the Wellcome Trust and a prestigious Watson-Crick DNA anniversary award from the Biotechnology and Biological Sciences Research Council (BBSRC), was led by the University of Nottinghams Professor Stephen Harding and Professor Judith Jesch and the University of Leicesters Professor Mark Jobling.

Stephen Harding, Professor of Physical Biochemistry in the School of Biosciences said; DNA on the male Y-chromosome is passed along the paternal line from generation to generation with very little change, providing a powerful probe into ancestry. So a mans Y-chromosome type is a marker to his paternal past. The method is most powerful when populations rather than individuals are compared with each other. We can also take advantage of the fact that surnames are also passed along the paternal generations. Using tax and other records the team selected volunteers who possess a surname present in the region prior to 1600. This gets round the problems of large population movements that have occurred since the Industrial revolution in places like Merseyside.

After their expulsion from Dublin in 902AD the Wirral Vikings, initially led by the Norwegian Viking INGIMUND, landed in their boats along the north Wirral coastline. Place names still reflect the North Wests Viking past. Aigburth, Formby, Crosby, Toxteth, Croxteth are all Viking names even the football team Tranmere is Viking. Thingwall is the name of a Viking parliament or assembly (Thingvellir in Iceland) and the only two in England are both in the North West one in Wirral and one in Liverpool.


'/>"/>

Contact: Stephen Harding
steve.harding@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

Related biology news :

1. Unravelling new complexity in the genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug ... Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( ... expected to deliver therapeutic levels of olanzapine for a period of 3 months., “We ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: